Neuer Antikörper bremst kognitiven Verfall
- PMID: 37081342
- DOI: 10.1007/s15006-023-2589-5
Neuer Antikörper bremst kognitiven Verfall
Comment on
-
Lecanemab in Early Alzheimer's Disease.N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29. N Engl J Med. 2023. PMID: 36449413 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources